![Tim McInerney](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: - $ in data 30/11/2025
Timothy McInerney is Director at Adgero Biopharmaceuticals Holdings, Inc. since 2016.
Managing Director at Castle Hill Capital Partners, Inc. since 2017.
Independent Non-Executive Director at Silence Therapeutics Plc starting 2025.
Director at Corino Therapeutics, Inc. Partner at Riverbank Capital Securities, Inc. since 2007.
Former Chairman at InSite Vision, Inc. from 2008 to 2015.
Director at Repros Therapeutics, Inc. Director at TG Therapeutics, Inc. from 2004 to 2011.
Managing Director at Paramount BioCapital, Inc. from 1992 to 2007.
Director at ZIOPHARM, Inc. in 2005.
Director at Edgemont Pharmaceuticals LLC.
Independent Director at Alaunos Therapeutics, Inc. from 2011 to 2015.
Independent Director at Emisphere Technologies, Inc. Principal at Bear, Stearns & Co., Inc. Principal at Two River Group Holdings LLC.
Education includes undergraduate degree from St. John's University.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 31/03/2026 | 0 ( -.--% ) | - $ | 30/11/2025 |
| Società | Posizione | Inizio |
|---|---|---|
| SILENCE THERAPEUTICS PLC | Direttore/Membro del Consiglio | 05/05/2025 |
Riverbank Capital Securities, Inc.
 Riverbank Capital Securities, Inc. Investment Banks/BrokersFinance Deals securities | Corporate Officer/Principal | 01/06/2007 |
Adgero Biopharmaceuticals Holdings, Inc.
 Adgero Biopharmaceuticals Holdings, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company focused on building a robust pipeline for oncology indications | Direttore/Membro del Consiglio | 01/04/2016 |
Castle Hill Capital Partners, Inc.
 Castle Hill Capital Partners, Inc. Investment Banks/BrokersFinance Provides investment management and strategy services | Corporate Officer/Principal | 01/05/2017 |
Corino Therapeutics, Inc.
 Corino Therapeutics, Inc. BiotechnologyHealth Technology Engages in developing and commercializing of biopharmaceutical products for the treatment of a variety of human diseases | Direttore/Membro del Consiglio | - |
| Società | Posizione | Fine |
|---|---|---|
| INSITE VISION INC. | Presidente | 02/11/2015 |
| ALAUNOS THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 18/06/2015 |
| TG THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 23/06/2011 |
Paramount BioCapital, Inc.
 Paramount BioCapital, Inc. Investment ManagersFinance Alternative investment manager | Corporate Officer/Principal | 01/03/2007 |
| ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 16 |
|---|---|
Bear, Stearns & Co., Inc.
 Bear, Stearns & Co., Inc. Investment Banks/BrokersFinance Provides investment banking, securities trading and brokerage Services | Finance |
Emisphere Technologies, Inc.
 Emisphere Technologies, Inc. Pharmaceuticals: MajorHealth Technology Operates as a commercial stage pharmaceutical and drug delivery company | Health Technology |
InSite Vision, Inc.
 InSite Vision, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets ophthalmic pharmaceutical products | Health Technology |
Repros Therapeutics, Inc.
 Repros Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs to treat hormonal and reproductive system disorders | Health Technology |
TG Therapeutics, Inc.
 TG Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Castle Hill Capital Partners, Inc.
Castle Hill Capital Partners, Inc. Investment Banks/BrokersFinance Provides investment management and strategy services | Finance |
Paramount BioCapital, Inc.
Paramount BioCapital, Inc. Investment ManagersFinance Alternative investment manager | Finance |
Two River Group Holdings LLC
 Two River Group Holdings LLC Investment ManagersFinance Two River Group invests in companies located in the United States. The firm focuses on life sciences and healthcare sectors. It participates in early stage capital requirements. | Finance |
ZIOPHARM, Inc.
 ZIOPHARM, Inc. Pharmaceuticals: MajorHealth Technology Develops cancer drugs | Health Technology |
Riverbank Capital Securities, Inc.
Riverbank Capital Securities, Inc. Investment Banks/BrokersFinance Deals securities | Finance |
Edgemont Pharmaceuticals LLC
 Edgemont Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Operates pharmaceutical company | Health Technology |
Silence Therapeutics Plc
 Silence Therapeutics Plc Miscellaneous Commercial ServicesCommercial Services Engages in the research and development of novel pharmaceutical products | Commercial Services |
St. John's University
 St. John's University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alaunos Therapeutics, Inc.
 Alaunos Therapeutics, Inc. BiotechnologyHealth Technology Develops a portfolio of immuno-oncology therapies | Health Technology |
Adgero Biopharmaceuticals Holdings, Inc.
Adgero Biopharmaceuticals Holdings, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company focused on building a robust pipeline for oncology indications | Health Technology |
Corino Therapeutics, Inc.
Corino Therapeutics, Inc. BiotechnologyHealth Technology Engages in developing and commercializing of biopharmaceutical products for the treatment of a variety of human diseases | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
